Immune Response News and Research

RSS

Study identifies genomic differences that impact response to Cryptococcus infection

Cryptococcus neoformans is a fungal pathogen that infects people with weakened immune systems, particularly those with advanced HIV/AIDS. New University of Minnesota Medical Research could mean a better understanding of this infection and potentially better treatments for patients.

16 Jul 2019

New method spots rare immune cells reactive against cancer

Researchers from the Garvan Institute of Medical Research have developed a new method to spot rare immune cells that are reactive against cancer cells, from within a patient's own immune system.

16 Jul 2019

Single-cell encapsulation technology can protect transplanted MSCs from immune attack

Bone marrow transplants of hematopoietic stem cells have become standard treatment for a host of conditions including cancers of the blood and lymphatic systems, sickle cell anemia, inherited metabolic disorders, and radiation damage.

16 Jul 2019

HIV therapy leaves unrepaired holes in the immune system's wall of defense

If they don't receive antiretroviral therapy (ART), most HIV patients see a progressive weakening of their immune system.

16 Jul 2019

New study reveals 'clutch' proteins responsible for putting T cell activation 'into gear'

In collaborative research, scientists from three continents were able to discover a crucial bit of information about how T cells move proteins inside them to drive the immune response. This could help evolve specific new treatments centered on T cell selectivity.

12 Jul 2019

Nanotechnology-based compound used to deliver hepatitis B vaccine

Nanotechnology-based compounds are now being tested as a possible delivery vehicle for vaccines. A team of researchers demonstrated how the oral delivery vehicle SBA-15, one such nanotechnology-based compound can deliver an oral vaccine against hepatitis B to the immune system.

11 Jul 2019

An injection of nanoparticles for spinal cord injuries

Researchers from the University of Michigan used nanopaticles injection to prevent the immune cells of the body from impairing the healing of injured brain and spinal cord. They call this an “EpiPen” or emergency rescue drug for the brain and spinal cord when they suffer trauma.

11 Jul 2019

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

The Scripps Consortium for HIV/AIDS Vaccine Development, an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV.

11 Jul 2019

Researchers explain how 'viral' agents of neurological diseases ended up in our DNA

What if the missing ‘environmental’ factor in some of our deadliest neurological diseases were really written in our genome?

11 Jul 2019

New shingles vaccine reduces outbreaks of painful rash among stem cell transplant patients

A newer form of shingles vaccine reduced outbreaks of the painful rash among patients who were transplanted with their own stem cells, according to a study led by a Duke Health researcher and published today in JAMA.

11 Jul 2019

Study shows how the mosquito immune system combats malaria parasites

A new study from Iowa State University entomologists describes how mosquitoes fight off parasites that cause malaria, a disease that sickens millions of people every year.

11 Jul 2019

Cancer killing capability of lesser-known immune cells identified

Researchers at Trinity College Dublin have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target.

10 Jul 2019

UMD researchers connect a protein to antibody immunity for the first time

Human cytomegalovirus may not be a household name as far as viruses go, but according to Xiaoping Zhu, professor and chair in Veterinary Medicine at UMD, half of the population walking around campus is likely to be a carrier.

10 Jul 2019

UM scientists receive $3.3 million NIH contract to develop opioid addiction vaccine

The University of Montana has received a $3.3 million contract from the National Institutes of Health to develop an innovative vaccine targeting opioid addiction.

10 Jul 2019

Special blood test may predict relapse risk for breast cancer patients

A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.

9 Jul 2019

Common cold virus strain could be a breakthrough in bladder cancer treatment

Scientists in the UK have found a new way to treat bladder cancer, using a strain of one of the viruses that cause the common cold. The virus is called Coxsackie virus CVA21, and it was found to be oncolytic, or tumor-destroying.

8 Jul 2019

New biomaterial could encapsulate and protect implanted insulin-producing cells

Transplanting insulin-producing pancreatic cells into people with type 1 diabetes has emerged as a ground-breaking treatment for millions of patients over the past few decades.

4 Jul 2019

Scientists identify mechanism that makes babies more likely than adults to die from sepsis

An immune mechanism that makes babies more likely than adults to die from sepsis has been identified by scientists affiliated with the Center for Research on Inflammatory Diseases in Ribeirão Preto, São Paulo State (Brazil).

4 Jul 2019

Non-pathogenic bacteria engineered as Trojan Horse to treat tumors from within

The emerging field of synthetic biology-designing new biological components and systems-is revolutionizing medicine.

4 Jul 2019

Immune-boosting compound could make pancreatic cancers susceptible to immunotherapy

Pancreatic cancer is especially challenging to treat – only eight percent of patients are still alive five years after diagnosis.

4 Jul 2019

Immune Response News and Research

Study identifies genomic differences that impact response to Cryptococcus infection

New method spots rare immune cells reactive against cancer

Single-cell encapsulation technology can protect transplanted MSCs from immune attack

HIV therapy leaves unrepaired holes in the immune system's wall of defense

New study reveals 'clutch' proteins responsible for putting T cell activation 'into gear'

Nanotechnology-based compound used to deliver hepatitis B vaccine

An injection of nanoparticles for spinal cord injuries

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

Researchers explain how 'viral' agents of neurological diseases ended up in our DNA

New shingles vaccine reduces outbreaks of painful rash among stem cell transplant patients

Study shows how the mosquito immune system combats malaria parasites

Cancer killing capability of lesser-known immune cells identified

UMD researchers connect a protein to antibody immunity for the first time

UM scientists receive $3.3 million NIH contract to develop opioid addiction vaccine

Special blood test may predict relapse risk for breast cancer patients

Common cold virus strain could be a breakthrough in bladder cancer treatment

New biomaterial could encapsulate and protect implanted insulin-producing cells

Scientists identify mechanism that makes babies more likely than adults to die from sepsis

Non-pathogenic bacteria engineered as Trojan Horse to treat tumors from within

Immune-boosting compound could make pancreatic cancers susceptible to immunotherapy

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News